Kaplan-Meier analysis showed that high levels of PSMA3 in CD138+ MM cells correlated with decreased progression-free survival and overall survival in patients with MM, and high levels of PSMA3 could also serve as an independent prognostic factor for patients with MM receiving bortezomib treatment. The gene discussed is SDC1; the disease is Miyoshi myopathy.